[ { "recordid": "GLY_000310_1_9001", "row": "[\"P01611-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9002", "row": "[\"P19174-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9003", "row": "[\"P01768-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9004", "row": "[\"P01762-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9005", "row": "[\"P01763-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9006", "row": "[\"P01764-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9007", "row": "[\"P01767-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9008", "row": "[\"O95622-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9009", "row": "[\"Q8NFM4-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9010", "row": "[\"P0DOY2-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9011", "row": "[\"P0DOY3-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9012", "row": "[\"A0M8Q6-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9013", "row": "[\"P01624-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9014", "row": "[\"P01597-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9015", "row": "[\"P01593-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9016", "row": "[\"P01599-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9017", "row": "[\"P01766-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9018", "row": "[\"P0CG04-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9019", "row": "[\"P80748-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9020", "row": "[\"P09769-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9021", "row": "[\"P01859-2\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9022", "row": "[\"P01857-2\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9023", "row": "[\"P13861-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9024", "row": "[\"P23083-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9025", "row": "[\"P01742-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9026", "row": "[\"P01743-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9027", "row": "[\"P06241-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9028", "row": "[\"P04430-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9029", "row": "[\"P01825-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9030", "row": "[\"P01824-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9031", "row": "[\"P0CF74-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9032", "row": "[\"Q08462-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9033", "row": "[\"A0A0C4DH73-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9034", "row": "[\"P22301-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9035", "row": "[\"P40145-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9036", "row": "[\"A2NJV5-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9037", "row": "[\"O60503-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9038", "row": "[\"P01834-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9039", "row": "[\"O43306-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9040", "row": "[\"P09693-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9041", "row": "[\"P04433-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9042", "row": "[\"P04432-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9043", "row": "[\"P07947-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9044", "row": "[\"P07948-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9045", "row": "[\"P16220-2\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9046", "row": "[\"P22612-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9047", "row": "[\"P06315-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9048", "row": "[\"O60266-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9049", "row": "[\"P22694-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9050", "row": "[\"P31323-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9051", "row": "[\"P31321-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9052", "row": "[\"P12314-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9053", "row": "[\"P12318-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9054", "row": "[\"P01817-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9055", "row": "[\"P01814-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9056", "row": "[\"P16885-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9057", "row": "[\"P01718-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9058", "row": "[\"P01782-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9059", "row": "[\"Q08828-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9060", "row": "[\"P01780-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9061", "row": "[\"A0A0C4DH25-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9062", "row": "[\"A0A075B6S6-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9063", "row": "[\"P43405-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9064", "row": "[\"P51817-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9065", "row": "[\"P01721-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9066", "row": "[\"P01594-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9067", "row": "[\"P01715-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9068", "row": "[\"P01714-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9069", "row": "[\"P01717-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9070", "row": "[\"P08637-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9071", "row": "[\"P08631-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9072", "row": "[\"P01699-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9073", "row": "[\"P06310-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9074", "row": "[\"O43865-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9075", "row": "[\"P06312-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9076", "row": "[\"P01703-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9077", "row": "[\"P01700-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9078", "row": "[\"P01701-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9079", "row": "[\"P01706-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9080", "row": "[\"P01704-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9081", "row": "[\"P01705-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9082", "row": "[\"P01709-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9083", "row": "[\"Q14643-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9084", "row": "[\"P01861-2\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9085", "row": "[\"P01860-2\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9086", "row": "[\"P10644-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9087", "row": "[\"A0A075B6P5-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9088", "row": "[\"P0DP23-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9089", "row": "[\"P01602-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9090", "row": "[\"P01601-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9091", "row": "[\"P51828-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9092", "row": "[\"P01772-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9093", "row": "[\"P06331-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9094", "row": "[\"P17612-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9095", "row": "[\"P04211-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9096", "row": "[\"Q14571-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9097", "row": "[\"Q14573-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9098", "row": "[\"P01619-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9099", "row": "[\"P01614-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9100", "row": "[\"P01615-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9101", "row": "[\"P01611-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9102", "row": "[\"P19174-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9103", "row": "[\"P01768-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9104", "row": "[\"P01762-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9105", "row": "[\"P01763-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9106", "row": "[\"P01764-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9107", "row": "[\"P01767-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9108", "row": "[\"O95622-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9109", "row": "[\"Q8NFM4-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9110", "row": "[\"P0DOY2-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9111", "row": "[\"P0DOY3-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9112", "row": "[\"A0M8Q6-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9113", "row": "[\"P01624-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9114", "row": "[\"P01597-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9115", "row": "[\"P01593-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9116", "row": "[\"P01599-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9117", "row": "[\"P01766-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9118", "row": "[\"P0CG04-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9119", "row": "[\"P80748-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9120", "row": "[\"P09769-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9121", "row": "[\"P01859-2\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9122", "row": "[\"P01857-2\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9123", "row": "[\"P13861-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9124", "row": "[\"P23083-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9125", "row": "[\"P01742-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9126", "row": "[\"P01743-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9127", "row": "[\"P06241-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9128", "row": "[\"P04430-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9129", "row": "[\"P01825-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9130", "row": "[\"P01824-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9131", "row": "[\"P0CF74-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9132", "row": "[\"Q08462-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9133", "row": "[\"A0A0C4DH73-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9134", "row": "[\"P22301-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9135", "row": "[\"P40145-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9136", "row": "[\"A2NJV5-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9137", "row": "[\"O60503-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9138", "row": "[\"P01834-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9139", "row": "[\"O43306-1\", \"Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.\", \"Infection and immunity\", \"2002 Aug\", \"Morehead J, Coppens I, Andrews NW\", \"protein_xref_pubmed\", \"12117970\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9140", "row": "[\"P09693-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9141", "row": "[\"P04433-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9142", "row": "[\"P04432-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9143", "row": "[\"P07947-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9144", "row": "[\"P07948-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9145", "row": "[\"P16220-2\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9146", "row": "[\"P22612-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9147", "row": "[\"P06315-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9148", "row": "[\"O60266-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9149", "row": "[\"P22694-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9150", "row": "[\"P31323-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9151", "row": "[\"P31321-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9152", "row": "[\"P12314-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9153", "row": "[\"P12318-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9154", "row": "[\"P01817-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9155", "row": "[\"P01814-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9156", "row": "[\"P16885-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9157", "row": "[\"P01718-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9158", "row": "[\"P01782-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9159", "row": "[\"Q08828-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9160", "row": "[\"P01780-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9161", "row": "[\"A0A0C4DH25-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9162", "row": "[\"A0A075B6S6-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9163", "row": "[\"P43405-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9164", "row": "[\"P51817-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9165", "row": "[\"P01721-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9166", "row": "[\"P01594-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9167", "row": "[\"P01715-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9168", "row": "[\"P01714-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9169", "row": "[\"P01717-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9170", "row": "[\"P08637-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9171", "row": "[\"P08631-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9172", "row": "[\"P01699-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9173", "row": "[\"P06310-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9174", "row": "[\"O43865-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9175", "row": "[\"P06312-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9176", "row": "[\"P01703-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9177", "row": "[\"P01700-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9178", "row": "[\"P01701-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9179", "row": "[\"P01706-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9180", "row": "[\"P01704-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9181", "row": "[\"P01705-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9182", "row": "[\"P01709-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9183", "row": "[\"Q14643-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9184", "row": "[\"P01861-2\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9185", "row": "[\"P01860-2\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9186", "row": "[\"P10644-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9187", "row": "[\"A0A075B6P5-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9188", "row": "[\"P0DP23-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9189", "row": "[\"P01602-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9190", "row": "[\"P01601-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9191", "row": "[\"P51828-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9192", "row": "[\"P01772-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9193", "row": "[\"P06331-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9194", "row": "[\"P17612-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9195", "row": "[\"P04211-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9196", "row": "[\"Q14571-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9197", "row": "[\"Q14573-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9198", "row": "[\"P01619-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9199", "row": "[\"P01614-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9200", "row": "[\"P01615-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9201", "row": "[\"P01611-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9202", "row": "[\"P19174-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9203", "row": "[\"P01768-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9204", "row": "[\"P01762-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9205", "row": "[\"P01763-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9206", "row": "[\"P01764-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9207", "row": "[\"P01767-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9208", "row": "[\"O95622-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9209", "row": "[\"Q8NFM4-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9210", "row": "[\"P0DOY2-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9211", "row": "[\"P0DOY3-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9212", "row": "[\"A0M8Q6-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9213", "row": "[\"P01624-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9214", "row": "[\"P01597-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9215", "row": "[\"P01593-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9216", "row": "[\"P01599-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9217", "row": "[\"P01766-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9218", "row": "[\"P0CG04-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9219", "row": "[\"P80748-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9220", "row": "[\"P09769-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9221", "row": "[\"P01859-2\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9222", "row": "[\"P01857-2\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9223", "row": "[\"P13861-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9224", "row": "[\"P23083-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9225", "row": "[\"P01742-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9226", "row": "[\"P01743-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9227", "row": "[\"P06241-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9228", "row": "[\"P04430-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9229", "row": "[\"P01825-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9230", "row": "[\"P01824-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9231", "row": "[\"P0CF74-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9232", "row": "[\"Q08462-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9233", "row": "[\"A0A0C4DH73-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9234", "row": "[\"P22301-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9235", "row": "[\"P40145-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9236", "row": "[\"A2NJV5-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9237", "row": "[\"O60503-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9238", "row": "[\"P01834-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9239", "row": "[\"O43306-1\", \"Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2005 May 15\", \"Padigel UM, Farrell JP\", \"protein_xref_pubmed\", \"15879134\", \"protein_xref_reactome\", \"R-HSA-9664323\"]" }, { "recordid": "GLY_000310_1_9240", "row": "[\"Q05397-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9241", "row": "[\"P15498-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9242", "row": "[\"Q9Y6W5-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9243", "row": "[\"O00401-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9244", "row": "[\"P35579-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9245", "row": "[\"Q8TF74-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9246", "row": "[\"Q8WUW1-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9247", "row": "[\"P61160-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9248", "row": "[\"P00519-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9249", "row": "[\"Q9Y4I1-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9250", "row": "[\"Q9Y2A7-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9251", "row": "[\"P60953-2\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9252", "row": "[\"Q9UKW4-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9253", "row": "[\"P61158-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9254", "row": "[\"P55160-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9255", "row": "[\"P63000-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9256", "row": "[\"Q9UQB8-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9257", "row": "[\"P52735-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9258", "row": "[\"Q9UKX2-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9259", "row": "[\"O00159-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9260", "row": "[\"Q14185-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9261", "row": "[\"P60709-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9262", "row": "[\"P42768-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9263", "row": "[\"P46108-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9264", "row": "[\"Q96JJ3-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9265", "row": "[\"A6NGB9-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9266", "row": "[\"Q9UPY6-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9267", "row": "[\"P28482-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9268", "row": "[\"Q7L576-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9269", "row": "[\"Q9HD67-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9270", "row": "[\"O15143-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9271", "row": "[\"O15145-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9272", "row": "[\"O15511-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9273", "row": "[\"O43516-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9274", "row": "[\"P27361-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9275", "row": "[\"Q96F07-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9276", "row": "[\"Q92556-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9277", "row": "[\"Q92558-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9278", "row": "[\"O15144-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9279", "row": "[\"P16333-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9280", "row": "[\"Q8IZP0-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9281", "row": "[\"Q92747-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9282", "row": "[\"Q13459-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9283", "row": "[\"Q9NYB9-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9284", "row": "[\"P59998-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9285", "row": "[\"Q06187-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9286", "row": "[\"P63261-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9287", "row": "[\"Q9NZQ3-1\", \"FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.\", \"Infection and immunity\", \"2008 Feb\", \"Thomas BN, Buxbaum LU\", \"protein_xref_pubmed\", \"18070890\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9288", "row": "[\"Q05397-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9289", "row": "[\"P15498-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9290", "row": "[\"Q9Y6W5-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9291", "row": "[\"O00401-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9292", "row": "[\"P35579-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9293", "row": "[\"Q8TF74-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9294", "row": "[\"Q8WUW1-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9295", "row": "[\"P61160-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9296", "row": "[\"P00519-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9297", "row": "[\"Q9Y4I1-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9298", "row": "[\"Q9Y2A7-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9299", "row": "[\"P60953-2\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9300", "row": "[\"Q9UKW4-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9301", "row": "[\"P61158-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9302", "row": "[\"P55160-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9303", "row": "[\"P63000-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9304", "row": "[\"Q9UQB8-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9305", "row": "[\"P52735-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9306", "row": "[\"Q9UKX2-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9307", "row": "[\"O00159-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9308", "row": "[\"Q14185-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9309", "row": "[\"P60709-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9310", "row": "[\"P42768-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9311", "row": "[\"P46108-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9312", "row": "[\"Q96JJ3-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9313", "row": "[\"A6NGB9-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9314", "row": "[\"Q9UPY6-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9315", "row": "[\"P28482-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9316", "row": "[\"Q7L576-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9317", "row": "[\"Q9HD67-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9318", "row": "[\"O15143-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9319", "row": "[\"O15145-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9320", "row": "[\"O15511-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9321", "row": "[\"O43516-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9322", "row": "[\"P27361-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9323", "row": "[\"Q96F07-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9324", "row": "[\"Q92556-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9325", "row": "[\"Q92558-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9326", "row": "[\"O15144-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9327", "row": "[\"P16333-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9328", "row": "[\"Q8IZP0-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9329", "row": "[\"Q92747-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9330", "row": "[\"Q13459-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9331", "row": "[\"Q9NYB9-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9332", "row": "[\"P59998-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9333", "row": "[\"Q06187-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9334", "row": "[\"P63261-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9335", "row": "[\"Q9NZQ3-1\", \"IgG1 is pathogenic in Leishmania mexicana infection.\", \"Journal of immunology (Baltimore, Md. : 1950)\", \"2010 Dec 1\", \"Chu N, Thomas BN, Patel SR, Buxbaum LU\", \"protein_xref_pubmed\", \"21037092\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9336", "row": "[\"Q05397-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9337", "row": "[\"P15498-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9338", "row": "[\"Q9Y6W5-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9339", "row": "[\"O00401-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9340", "row": "[\"P35579-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9341", "row": "[\"Q8TF74-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9342", "row": "[\"Q8WUW1-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9343", "row": "[\"P61160-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9344", "row": "[\"P00519-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9345", "row": "[\"Q9Y4I1-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9346", "row": "[\"Q9Y2A7-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9347", "row": "[\"P60953-2\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9348", "row": "[\"Q9UKW4-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9349", "row": "[\"P61158-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9350", "row": "[\"P55160-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9351", "row": "[\"P63000-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9352", "row": "[\"Q9UQB8-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9353", "row": "[\"P52735-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9354", "row": "[\"Q9UKX2-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9355", "row": "[\"O00159-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9356", "row": "[\"Q14185-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9357", "row": "[\"P60709-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9358", "row": "[\"P42768-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9359", "row": "[\"P46108-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9360", "row": "[\"Q96JJ3-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9361", "row": "[\"A6NGB9-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9362", "row": "[\"Q9UPY6-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9363", "row": "[\"P28482-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9364", "row": "[\"Q7L576-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9365", "row": "[\"Q9HD67-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9366", "row": "[\"O15143-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9367", "row": "[\"O15145-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9368", "row": "[\"O15511-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9369", "row": "[\"O43516-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9370", "row": "[\"P27361-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9371", "row": "[\"Q96F07-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9372", "row": "[\"Q92556-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9373", "row": "[\"Q92558-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9374", "row": "[\"O15144-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9375", "row": "[\"P16333-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9376", "row": "[\"Q8IZP0-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9377", "row": "[\"Q92747-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9378", "row": "[\"Q13459-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9379", "row": "[\"Q9NYB9-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9380", "row": "[\"P59998-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9381", "row": "[\"Q06187-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9382", "row": "[\"P63261-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9383", "row": "[\"Q9NZQ3-1\", \"Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.\", \"PLoS neglected tropical diseases\", \"2013\", \"Buxbaum LU\", \"protein_xref_pubmed\", \"23675550\", \"protein_xref_reactome\", \"R-HSA-9664422\"]" }, { "recordid": "GLY_000310_1_9384", "row": "[\"P21964-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9385", "row": "[\"P05556-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9386", "row": "[\"P11912-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9387", "row": "[\"P07437-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9388", "row": "[\"P15498-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9389", "row": "[\"P09958-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9390", "row": "[\"P62942-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9391", "row": "[\"P04433-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9392", "row": "[\"P04432-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9393", "row": "[\"P05023-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9394", "row": "[\"P05026-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9395", "row": "[\"Q9H171-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9396", "row": "[\"Q14839-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9397", "row": "[\"P04150-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9398", "row": "[\"P06315-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9399", "row": "[\"Q9P0W2-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9400", "row": "[\"P52630-3\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9401", "row": "[\"P08238-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9402", "row": "[\"P13612-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9403", "row": "[\"Q9HAJ7-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9404", "row": "[\"P12268-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9405", "row": "[\"P29374-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9406", "row": "[\"P54710-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9407", "row": "[\"Q16236-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9408", "row": "[\"P40259-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9409", "row": "[\"Q12873-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9410", "row": "[\"P01817-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9411", "row": "[\"P01814-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9412", "row": "[\"P16885-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9413", "row": "[\"P38484-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9414", "row": "[\"P01718-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9415", "row": "[\"P01782-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9416", "row": "[\"Q9H7L9-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9417", "row": "[\"P01780-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9418", "row": "[\"A0A0C4DH25-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9419", "row": "[\"O60674-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9420", "row": "[\"A0A075B6S6-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9421", "row": "[\"Q8WXI9-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9422", "row": "[\"P43405-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9423", "row": "[\"P54709-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9424", "row": "[\"P58549-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9425", "row": "[\"P01721-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9426", "row": "[\"Q13127-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9427", "row": "[\"P13637-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9428", "row": "[\"P59646-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9429", "row": "[\"Q13546-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9430", "row": "[\"P01594-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9431", "row": "[\"P20839-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9432", "row": "[\"Q8WV28-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9433", "row": "[\"O60885-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9434", "row": "[\"P14778-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9435", "row": "[\"P01715-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9436", "row": "[\"P01714-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9437", "row": "[\"P01717-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9438", "row": "[\"P01699-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9439", "row": "[\"P06310-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9440", "row": "[\"Q96SW2-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9441", "row": "[\"Q9H0Q3-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9442", "row": "[\"P63010-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9443", "row": "[\"P08887-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9444", "row": "[\"Q9HCU9-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9445", "row": "[\"Q9UKL0-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9446", "row": "[\"Q9BYF1-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9447", "row": "[\"Q9BTC8-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9448", "row": "[\"Q99720-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9449", "row": "[\"P06312-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9450", "row": "[\"P01703-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9451", "row": "[\"P01700-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9452", "row": "[\"P01701-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9453", "row": "[\"P01706-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9454", "row": "[\"P01704-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9455", "row": "[\"P01705-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9456", "row": "[\"P01709-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9457", "row": "[\"O94776-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9458", "row": "[\"Q07889-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9459", "row": "[\"P01880-2\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9460", "row": "[\"A0A075B6P5-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9461", "row": "[\"Q13733-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9462", "row": "[\"P01602-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9463", "row": "[\"P01601-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9464", "row": "[\"P01772-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9465", "row": "[\"P06331-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9466", "row": "[\"Q96CW1-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9467", "row": "[\"Q13464-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9468", "row": "[\"O00422-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9469", "row": "[\"P04211-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9470", "row": "[\"P01871-2\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9471", "row": "[\"P49354-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9472", "row": "[\"P49356-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9473", "row": "[\"Q15185-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9474", "row": "[\"P50993-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9475", "row": "[\"P01619-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9476", "row": "[\"P01614-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9477", "row": "[\"P01615-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9478", "row": "[\"P01611-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9479", "row": "[\"P21453-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9480", "row": "[\"P29597-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9481", "row": "[\"P01768-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9482", "row": "[\"P01762-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9483", "row": "[\"P01763-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9484", "row": "[\"P01764-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9485", "row": "[\"P01767-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9486", "row": "[\"P62877-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9487", "row": "[\"Q02790-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9488", "row": "[\"Q96B97-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9489", "row": "[\"P53680-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9490", "row": "[\"O75446-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9491", "row": "[\"Q9UHD2-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9492", "row": "[\"Q9NYK1-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9493", "row": "[\"P0DOY2-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9494", "row": "[\"P0DOY3-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9495", "row": "[\"Q14145-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9496", "row": "[\"Q9NR96-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9497", "row": "[\"A0M8Q6-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9498", "row": "[\"P01624-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9499", "row": "[\"P15260-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9500", "row": "[\"P01597-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9501", "row": "[\"P01593-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9502", "row": "[\"P01599-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9503", "row": "[\"P01766-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9504", "row": "[\"P0CG04-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9505", "row": "[\"P80748-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9506", "row": "[\"P52333-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9507", "row": "[\"Q15116-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9508", "row": "[\"P23083-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9509", "row": "[\"P16333-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9510", "row": "[\"Q92769-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9511", "row": "[\"Q09028-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9512", "row": "[\"P23458-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9513", "row": "[\"O60341-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9514", "row": "[\"O00168-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9515", "row": "[\"P01742-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9516", "row": "[\"P01743-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9517", "row": "[\"O95782-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9518", "row": "[\"O95983-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9519", "row": "[\"P04430-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9520", "row": "[\"O75116-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9521", "row": "[\"Q86YP4-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9522", "row": "[\"P01825-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9523", "row": "[\"P01824-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9524", "row": "[\"P0CF74-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9525", "row": "[\"Q06187-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9526", "row": "[\"P07900-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9527", "row": "[\"P14415-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9528", "row": "[\"A0A0C4DH73-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9529", "row": "[\"Q9Y271-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9530", "row": "[\"Q13547-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9531", "row": "[\"Q13330-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9532", "row": "[\"Q16576-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9533", "row": "[\"O94973-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9534", "row": "[\"P17181-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9535", "row": "[\"A2NJV5-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9536", "row": "[\"Q13618-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9537", "row": "[\"P01834-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9538", "row": "[\"Q14802-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9539", "row": "[\"Q4LE39-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9540", "row": "[\"Q96BD5-1\", \"Identification of a primary target of thalidomide teratogenicity.\", \"Science (New York, N.Y.)\", \"2010 Mar 12\", \"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H\", \"protein_xref_pubmed\", \"20223979\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9541", "row": "[\"P21964-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9542", "row": "[\"P05556-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9543", "row": "[\"P11912-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9544", "row": "[\"P07437-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9545", "row": "[\"P15498-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9546", "row": "[\"P09958-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9547", "row": "[\"P62942-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9548", "row": "[\"P04433-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9549", "row": "[\"P04432-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9550", "row": "[\"P05023-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9551", "row": "[\"P05026-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9552", "row": "[\"Q9H171-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9553", "row": "[\"Q14839-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9554", "row": "[\"P04150-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9555", "row": "[\"P06315-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9556", "row": "[\"Q9P0W2-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9557", "row": "[\"P52630-3\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9558", "row": "[\"P08238-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9559", "row": "[\"P13612-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9560", "row": "[\"Q9HAJ7-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9561", "row": "[\"P12268-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9562", "row": "[\"P29374-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9563", "row": "[\"P54710-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9564", "row": "[\"Q16236-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9565", "row": "[\"P40259-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9566", "row": "[\"Q12873-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9567", "row": "[\"P01817-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9568", "row": "[\"P01814-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9569", "row": "[\"P16885-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9570", "row": "[\"P38484-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9571", "row": "[\"P01718-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9572", "row": "[\"P01782-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9573", "row": "[\"Q9H7L9-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9574", "row": "[\"P01780-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9575", "row": "[\"A0A0C4DH25-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9576", "row": "[\"O60674-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9577", "row": "[\"A0A075B6S6-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9578", "row": "[\"Q8WXI9-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9579", "row": "[\"P43405-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9580", "row": "[\"P54709-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9581", "row": "[\"P58549-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9582", "row": "[\"P01721-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9583", "row": "[\"Q13127-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9584", "row": "[\"P13637-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9585", "row": "[\"P59646-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9586", "row": "[\"Q13546-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9587", "row": "[\"P01594-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9588", "row": "[\"P20839-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9589", "row": "[\"Q8WV28-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9590", "row": "[\"O60885-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9591", "row": "[\"P14778-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9592", "row": "[\"P01715-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9593", "row": "[\"P01714-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9594", "row": "[\"P01717-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9595", "row": "[\"P01699-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9596", "row": "[\"P06310-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9597", "row": "[\"Q96SW2-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9598", "row": "[\"Q9H0Q3-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9599", "row": "[\"P63010-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9600", "row": "[\"P08887-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9601", "row": "[\"Q9HCU9-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9602", "row": "[\"Q9UKL0-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9603", "row": "[\"Q9BYF1-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9604", "row": "[\"Q9BTC8-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9605", "row": "[\"Q99720-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9606", "row": "[\"P06312-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9607", "row": "[\"P01703-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9608", "row": "[\"P01700-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9609", "row": "[\"P01701-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9610", "row": "[\"P01706-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9611", "row": "[\"P01704-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9612", "row": "[\"P01705-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9613", "row": "[\"P01709-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9614", "row": "[\"O94776-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9615", "row": "[\"Q07889-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9616", "row": "[\"P01880-2\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9617", "row": "[\"A0A075B6P5-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9618", "row": "[\"Q13733-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9619", "row": "[\"P01602-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9620", "row": "[\"P01601-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9621", "row": "[\"P01772-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9622", "row": "[\"P06331-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9623", "row": "[\"Q96CW1-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9624", "row": "[\"Q13464-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9625", "row": "[\"O00422-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9626", "row": "[\"P04211-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9627", "row": "[\"P01871-2\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9628", "row": "[\"P49354-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9629", "row": "[\"P49356-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9630", "row": "[\"Q15185-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9631", "row": "[\"P50993-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9632", "row": "[\"P01619-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9633", "row": "[\"P01614-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9634", "row": "[\"P01615-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9635", "row": "[\"P01611-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9636", "row": "[\"P21453-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9637", "row": "[\"P29597-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9638", "row": "[\"P01768-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9639", "row": "[\"P01762-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9640", "row": "[\"P01763-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9641", "row": "[\"P01764-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9642", "row": "[\"P01767-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9643", "row": "[\"P62877-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9644", "row": "[\"Q02790-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9645", "row": "[\"Q96B97-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9646", "row": "[\"P53680-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9647", "row": "[\"O75446-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9648", "row": "[\"Q9UHD2-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9649", "row": "[\"Q9NYK1-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9650", "row": "[\"P0DOY2-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9651", "row": "[\"P0DOY3-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9652", "row": "[\"Q14145-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9653", "row": "[\"Q9NR96-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9654", "row": "[\"A0M8Q6-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9655", "row": "[\"P01624-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9656", "row": "[\"P15260-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9657", "row": "[\"P01597-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9658", "row": "[\"P01593-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9659", "row": "[\"P01599-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9660", "row": "[\"P01766-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9661", "row": "[\"P0CG04-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9662", "row": "[\"P80748-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9663", "row": "[\"P52333-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9664", "row": "[\"Q15116-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9665", "row": "[\"P23083-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9666", "row": "[\"P16333-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9667", "row": "[\"Q92769-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9668", "row": "[\"Q09028-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9669", "row": "[\"P23458-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9670", "row": "[\"O60341-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9671", "row": "[\"O00168-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9672", "row": "[\"P01742-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9673", "row": "[\"P01743-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9674", "row": "[\"O95782-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9675", "row": "[\"O95983-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9676", "row": "[\"P04430-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9677", "row": "[\"O75116-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9678", "row": "[\"Q86YP4-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9679", "row": "[\"P01825-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9680", "row": "[\"P01824-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9681", "row": "[\"P0CF74-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9682", "row": "[\"Q06187-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9683", "row": "[\"P07900-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9684", "row": "[\"P14415-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9685", "row": "[\"A0A0C4DH73-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9686", "row": "[\"Q9Y271-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9687", "row": "[\"Q13547-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9688", "row": "[\"Q13330-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9689", "row": "[\"Q16576-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9690", "row": "[\"O94973-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9691", "row": "[\"P17181-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9692", "row": "[\"A2NJV5-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9693", "row": "[\"Q13618-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9694", "row": "[\"P01834-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9695", "row": "[\"Q14802-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9696", "row": "[\"Q4LE39-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9697", "row": "[\"Q96BD5-1\", \"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.\", \"Leukemia\", \"2012 Nov\", \"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M, Mahmoudi A, Cathers B, Rychak E, Gaidarova S, Chen R, Schafer PH, Handa H, Daniel TO, Evans JF, Chopra R\", \"protein_xref_pubmed\", \"22552008\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9698", "row": "[\"P21964-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9699", "row": "[\"P05556-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9700", "row": "[\"P11912-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9701", "row": "[\"P07437-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9702", "row": "[\"P15498-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9703", "row": "[\"P09958-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9704", "row": "[\"P62942-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9705", "row": "[\"P04433-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9706", "row": "[\"P04432-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9707", "row": "[\"P05023-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9708", "row": "[\"P05026-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9709", "row": "[\"Q9H171-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9710", "row": "[\"Q14839-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9711", "row": "[\"P04150-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9712", "row": "[\"P06315-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9713", "row": "[\"Q9P0W2-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9714", "row": "[\"P52630-3\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9715", "row": "[\"P08238-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9716", "row": "[\"P13612-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9717", "row": "[\"Q9HAJ7-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9718", "row": "[\"P12268-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9719", "row": "[\"P29374-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9720", "row": "[\"P54710-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9721", "row": "[\"Q16236-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9722", "row": "[\"P40259-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9723", "row": "[\"Q12873-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9724", "row": "[\"P01817-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9725", "row": "[\"P01814-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9726", "row": "[\"P16885-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9727", "row": "[\"P38484-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9728", "row": "[\"P01718-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9729", "row": "[\"P01782-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9730", "row": "[\"Q9H7L9-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9731", "row": "[\"P01780-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9732", "row": "[\"A0A0C4DH25-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9733", "row": "[\"O60674-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9734", "row": "[\"A0A075B6S6-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9735", "row": "[\"Q8WXI9-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9736", "row": "[\"P43405-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9737", "row": "[\"P54709-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9738", "row": "[\"P58549-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9739", "row": "[\"P01721-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9740", "row": "[\"Q13127-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9741", "row": "[\"P13637-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9742", "row": "[\"P59646-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9743", "row": "[\"Q13546-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9744", "row": "[\"P01594-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9745", "row": "[\"P20839-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9746", "row": "[\"Q8WV28-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9747", "row": "[\"O60885-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9748", "row": "[\"P14778-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9749", "row": "[\"P01715-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9750", "row": "[\"P01714-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9751", "row": "[\"P01717-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9752", "row": "[\"P01699-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9753", "row": "[\"P06310-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9754", "row": "[\"Q96SW2-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9755", "row": "[\"Q9H0Q3-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9756", "row": "[\"P63010-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9757", "row": "[\"P08887-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9758", "row": "[\"Q9HCU9-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9759", "row": "[\"Q9UKL0-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9760", "row": "[\"Q9BYF1-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9761", "row": "[\"Q9BTC8-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9762", "row": "[\"Q99720-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9763", "row": "[\"P06312-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9764", "row": "[\"P01703-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9765", "row": "[\"P01700-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9766", "row": "[\"P01701-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9767", "row": "[\"P01706-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9768", "row": "[\"P01704-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9769", "row": "[\"P01705-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9770", "row": "[\"P01709-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9771", "row": "[\"O94776-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9772", "row": "[\"Q07889-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9773", "row": "[\"P01880-2\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9774", "row": "[\"A0A075B6P5-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9775", "row": "[\"Q13733-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9776", "row": "[\"P01602-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9777", "row": "[\"P01601-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9778", "row": "[\"P01772-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9779", "row": "[\"P06331-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9780", "row": "[\"Q96CW1-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9781", "row": "[\"Q13464-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9782", "row": "[\"O00422-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9783", "row": "[\"P04211-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9784", "row": "[\"P01871-2\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9785", "row": "[\"P49354-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9786", "row": "[\"P49356-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9787", "row": "[\"Q15185-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9788", "row": "[\"P50993-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9789", "row": "[\"P01619-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9790", "row": "[\"P01614-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9791", "row": "[\"P01615-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9792", "row": "[\"P01611-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9793", "row": "[\"P21453-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9794", "row": "[\"P29597-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9795", "row": "[\"P01768-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9796", "row": "[\"P01762-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9797", "row": "[\"P01763-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9798", "row": "[\"P01764-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9799", "row": "[\"P01767-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9800", "row": "[\"P62877-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9801", "row": "[\"Q02790-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9802", "row": "[\"Q96B97-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9803", "row": "[\"P53680-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9804", "row": "[\"O75446-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9805", "row": "[\"Q9UHD2-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9806", "row": "[\"Q9NYK1-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9807", "row": "[\"P0DOY2-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9808", "row": "[\"P0DOY3-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9809", "row": "[\"Q14145-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9810", "row": "[\"Q9NR96-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9811", "row": "[\"A0M8Q6-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9812", "row": "[\"P01624-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9813", "row": "[\"P15260-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9814", "row": "[\"P01597-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9815", "row": "[\"P01593-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9816", "row": "[\"P01599-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9817", "row": "[\"P01766-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9818", "row": "[\"P0CG04-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9819", "row": "[\"P80748-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9820", "row": "[\"P52333-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9821", "row": "[\"Q15116-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9822", "row": "[\"P23083-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9823", "row": "[\"P16333-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9824", "row": "[\"Q92769-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9825", "row": "[\"Q09028-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9826", "row": "[\"P23458-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9827", "row": "[\"O60341-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9828", "row": "[\"O00168-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9829", "row": "[\"P01742-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9830", "row": "[\"P01743-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9831", "row": "[\"O95782-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9832", "row": "[\"O95983-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9833", "row": "[\"P04430-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9834", "row": "[\"O75116-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9835", "row": "[\"Q86YP4-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9836", "row": "[\"P01825-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9837", "row": "[\"P01824-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9838", "row": "[\"P0CF74-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9839", "row": "[\"Q06187-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9840", "row": "[\"P07900-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9841", "row": "[\"P14415-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9842", "row": "[\"A0A0C4DH73-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9843", "row": "[\"Q9Y271-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9844", "row": "[\"Q13547-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9845", "row": "[\"Q13330-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9846", "row": "[\"Q16576-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9847", "row": "[\"O94973-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9848", "row": "[\"P17181-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9849", "row": "[\"A2NJV5-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9850", "row": "[\"Q13618-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9851", "row": "[\"P01834-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9852", "row": "[\"Q14802-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9853", "row": "[\"Q4LE39-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9854", "row": "[\"Q96BD5-1\", \"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.\", \"Blood\", \"2015 Aug 6\", \"Hagner PR, Man HW, Fontanillo C, Wang M, Couto S, Breider M, Bjorklund C, Havens CG, Lu G, Rychak E, Raymon H, Narla RK, Barnes L, Khambatta G, Chiu H, Kosek J, Kang J, Amantangelo MD, Waldman M, Lopez-Girona A, Cai T, Pourdehnad M, Trotter M, Daniel TO, Schafer PH, Klippel A, Thakurta A, Chopra R, Gandhi AK\", \"protein_xref_pubmed\", \"26002965\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9855", "row": "[\"P21964-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9856", "row": "[\"P05556-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9857", "row": "[\"P11912-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9858", "row": "[\"P07437-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9859", "row": "[\"P15498-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9860", "row": "[\"P09958-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9861", "row": "[\"P62942-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9862", "row": "[\"P04433-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9863", "row": "[\"P04432-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9864", "row": "[\"P05023-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9865", "row": "[\"P05026-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9866", "row": "[\"Q9H171-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9867", "row": "[\"Q14839-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9868", "row": "[\"P04150-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9869", "row": "[\"P06315-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9870", "row": "[\"Q9P0W2-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9871", "row": "[\"P52630-3\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9872", "row": "[\"P08238-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9873", "row": "[\"P13612-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9874", "row": "[\"Q9HAJ7-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9875", "row": "[\"P12268-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9876", "row": "[\"P29374-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9877", "row": "[\"P54710-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9878", "row": "[\"Q16236-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9879", "row": "[\"P40259-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9880", "row": "[\"Q12873-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9881", "row": "[\"P01817-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9882", "row": "[\"P01814-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9883", "row": "[\"P16885-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9884", "row": "[\"P38484-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9885", "row": "[\"P01718-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9886", "row": "[\"P01782-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9887", "row": "[\"Q9H7L9-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9888", "row": "[\"P01780-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9889", "row": "[\"A0A0C4DH25-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9890", "row": "[\"O60674-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9891", "row": "[\"A0A075B6S6-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9892", "row": "[\"Q8WXI9-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9893", "row": "[\"P43405-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9894", "row": "[\"P54709-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9895", "row": "[\"P58549-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9896", "row": "[\"P01721-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9897", "row": "[\"Q13127-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9898", "row": "[\"P13637-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9899", "row": "[\"P59646-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9900", "row": "[\"Q13546-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9901", "row": "[\"P01594-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9902", "row": "[\"P20839-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9903", "row": "[\"Q8WV28-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9904", "row": "[\"O60885-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9905", "row": "[\"P14778-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9906", "row": "[\"P01715-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9907", "row": "[\"P01714-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9908", "row": "[\"P01717-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9909", "row": "[\"P01699-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9910", "row": "[\"P06310-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9911", "row": "[\"Q96SW2-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9912", "row": "[\"Q9H0Q3-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9913", "row": "[\"P63010-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9914", "row": "[\"P08887-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9915", "row": "[\"Q9HCU9-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9916", "row": "[\"Q9UKL0-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9917", "row": "[\"Q9BYF1-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9918", "row": "[\"Q9BTC8-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9919", "row": "[\"Q99720-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9920", "row": "[\"P06312-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9921", "row": "[\"P01703-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9922", "row": "[\"P01700-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9923", "row": "[\"P01701-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9924", "row": "[\"P01706-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9925", "row": "[\"P01704-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9926", "row": "[\"P01705-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9927", "row": "[\"P01709-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9928", "row": "[\"O94776-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9929", "row": "[\"Q07889-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9930", "row": "[\"P01880-2\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9931", "row": "[\"A0A075B6P5-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9932", "row": "[\"Q13733-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9933", "row": "[\"P01602-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9934", "row": "[\"P01601-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9935", "row": "[\"P01772-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9936", "row": "[\"P06331-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9937", "row": "[\"Q96CW1-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9938", "row": "[\"Q13464-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9939", "row": "[\"O00422-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9940", "row": "[\"P04211-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9941", "row": "[\"P01871-2\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9942", "row": "[\"P49354-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9943", "row": "[\"P49356-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9944", "row": "[\"Q15185-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9945", "row": "[\"P50993-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9946", "row": "[\"P01619-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9947", "row": "[\"P01614-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9948", "row": "[\"P01615-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9949", "row": "[\"P01611-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9950", "row": "[\"P21453-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9951", "row": "[\"P29597-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9952", "row": "[\"P01768-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9953", "row": "[\"P01762-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9954", "row": "[\"P01763-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9955", "row": "[\"P01764-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9956", "row": "[\"P01767-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9957", "row": "[\"P62877-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9958", "row": "[\"Q02790-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9959", "row": "[\"Q96B97-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9960", "row": "[\"P53680-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9961", "row": "[\"O75446-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9962", "row": "[\"Q9UHD2-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9963", "row": "[\"Q9NYK1-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9964", "row": "[\"P0DOY2-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9965", "row": "[\"P0DOY3-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9966", "row": "[\"Q14145-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9967", "row": "[\"Q9NR96-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9968", "row": "[\"A0M8Q6-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9969", "row": "[\"P01624-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9970", "row": "[\"P15260-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9971", "row": "[\"P01597-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9972", "row": "[\"P01593-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9973", "row": "[\"P01599-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9974", "row": "[\"P01766-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9975", "row": "[\"P0CG04-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9976", "row": "[\"P80748-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9977", "row": "[\"P52333-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9978", "row": "[\"Q15116-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9979", "row": "[\"P23083-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9980", "row": "[\"P16333-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9981", "row": "[\"Q92769-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9982", "row": "[\"Q09028-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9983", "row": "[\"P23458-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9984", "row": "[\"O60341-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9985", "row": "[\"O00168-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9986", "row": "[\"P01742-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9987", "row": "[\"P01743-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9988", "row": "[\"O95782-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9989", "row": "[\"O95983-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9990", "row": "[\"P04430-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9991", "row": "[\"O75116-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9992", "row": "[\"Q86YP4-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9993", "row": "[\"P01825-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9994", "row": "[\"P01824-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9995", "row": "[\"P0CF74-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9996", "row": "[\"Q06187-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9997", "row": "[\"P07900-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9998", "row": "[\"P14415-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_9999", "row": "[\"A0A0C4DH73-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" }, { "recordid": "GLY_000310_1_10000", "row": "[\"Q9Y271-1\", \"A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.\", \"Journal of medicinal chemistry\", \"2018 Jan 25\", \"Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G, Lu CC, Lu G, Riley M, Satoh Y, Schafer P, Daniel TO, Carmichael J, Cathers BE, Chamberlain PP\", \"protein_xref_pubmed\", \"28425720\", \"protein_xref_reactome\", \"R-HSA-9679191\"]" } ]